4//SEC Filing
Donoghoe Nicholas 4
Accession 0001415889-25-021280
CIK 0001551152other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:00 PM ET
Size
7.2 KB
Accession
0001415889-25-021280
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
Transactions
- Sale
Common Stock, $0.01 par value
2025-08-05$198.27/sh−3,234.17$641,239→ 68,308 total - Sale
Common Stock, $0.01 par value
2025-08-05$198.59/sh−10,061$1,998,014→ 58,247 total
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.26 to $198.37 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]This reflects shares acquired pursuant to a dividend reinvestment plan.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.56 to $198.73 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001762951
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 5:00 PM ET
- Size
- 7.2 KB